Biblio
Export 1081 results:
Author Title [ Type] Year Filters: First Letter Of Last Name is T [Clear All Filters]
“Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.”, J Alzheimers Dis, vol. 82, no. 3, pp. 883-898, 2021.
, “Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.”, J Alzheimers Dis, vol. 82, no. 3, pp. 883-898, 2021.
, “Dementia Care Competence Among Care Professionals and Reduced Challenging Behavior of Home-Dwelling Persons with Dementia: A Pre- and Post-Intervention Data Analysis.”, J Alzheimers Dis, vol. 64, no. 2, pp. 515-523, 2018.
, “Dementia Care Competence Among Care Professionals and Reduced Challenging Behavior of Home-Dwelling Persons with Dementia: A Pre- and Post-Intervention Data Analysis.”, J Alzheimers Dis, vol. 64, no. 2, pp. 515-523, 2018.
, “Dementia Care in the Time of COVID-19 Pandemic.”, J Alzheimers Dis, vol. 76, no. 2, pp. 475-479, 2020.
, “Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain.”, J Alzheimers Dis, vol. 76, no. 1, pp. 33-40, 2020.
, “Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain.”, J Alzheimers Dis, vol. 76, no. 1, pp. 33-40, 2020.
, “Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.”, J Clin Invest, vol. 122, no. 4, pp. 1316-38, 2012.
, “Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.”, J Clin Invest, vol. 122, no. 4, pp. 1316-38, 2012.
, “Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1213-1221, 2018.
, “Depression and Dementia: The Role of Cortisol and Vascular Brain Lesions. AGES-Reykjavik Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1677-1687, 2021.
, “Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 3, pp. 743-54, 2016.
, “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
, “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
, “Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?”, J Alzheimers Dis, vol. 78, no. 1, pp. 405-412, 2020.
, “Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?”, J Alzheimers Dis, vol. 78, no. 1, pp. 405-412, 2020.
, “Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?”, J Alzheimers Dis, vol. 78, no. 1, pp. 405-412, 2020.
, “Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?”, J Alzheimers Dis, vol. 78, no. 1, pp. 405-412, 2020.
, “Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.”, J Alzheimers Dis, vol. 52, no. 3, pp. 863-73, 2016.
, “Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1259-1272, 2016.
, “Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions.”, J Alzheimers Dis, vol. 71, no. 3, pp. 715-732, 2019.
, “Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions.”, J Alzheimers Dis, vol. 71, no. 3, pp. 715-732, 2019.
, “Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1417-1430, 2020.
, “Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1417-1430, 2020.
, “Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.”, J Alzheimers Dis, vol. 49, no. 2, pp. 423-32, 2016.
,